LONDON, Fev. 6, 2018 /PRNewswire/ -- Global Influenza Medication Market: Overview
This report on Influenza Medication Market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of Influenza Medication Market products such as Zanamivir, Oseltamivir, Peramivir, and others as well as new entrants planning to enter this market. Download the full report: https://www.reportbuyer.com/product/5309060
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the Global Influenza Medication Market with respect to the leading market segments based on products segment, distribution channels, and geographies. Global Influenza Medication Market: Key Segments
Based on the product type, the Influenza Medication Market has been segmented into: Zanamivir, Oseltamivir, Peramivir, Amantadine, Rimantadine, Inosine and Others (laninamivir octanoate, etc.). Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of Influenza Medication Market products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year. Global Influenza Medication Market: Scope of the Study
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the Influenza Medication Market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global influenza medication market. Global Influenza Medication Market: Regional Outlook
Geographically, influenza medication market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter's five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the Global Influenza Medication Market. Companies Mentioned in Report
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the Global Influenza Medication Market. The report also profiles key players operating in the Influenza Medication Market which are Daiichi Sankyo Company, GlaxoSmithKline plc, Natco Pharma, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd. and Mylan, Inc.. The global influenza medication market is segmented as follows:
Global Influenza Medication Market, by Product
Zanamivir Oseltamivir Peramivir Amantadine Rimantadine Inosine Other (Laninamivir Octanoate, etc.) Global Influenza Medication Market, by Distribution channel
Hospitals Clinics Pharmacies Others Global Influenza Medication Market, by Geography
North America
U.S. Canada
Europe
Germany
U.K. France
Italy
Spain
Poland
Rest of the Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE Rest of Middle East & AfricaDownload the full report: https://www.reportbuyer.com/product/5309060
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (718) 213 4904 Website: www.reportbuyer.com
Advertisement
View original content:http://www.prnewswire.com/news-releases/influenza-medication-market---global-industry-analysis-size-share-growth-trends--forecast-2017---2025-300594314.html
SOURCE ReportBuyer
